Search research articles
Contact Us
Filters
Showing results (161-170 of 188) with videos related to
Page
of 19
Sort By:
Blood
|
March 24, 2025
Daratumumab-Bortezomib-Thalidomide-Dexamethasone for Newly Diagnosed Myeloma: CASSIOPEIA Minimal Residual Disease Results
Jill Corre, Laure Vincent, Philippe Moreau, et al.
Blood
|
May 27, 2016
Safety and efficacy of pomalidomide plus low-dose dexamethasone in STRATUS (MM-010): a phase 3b study in refractory multiple myeloma
Meletios A Dimopoulos, Antonio Palumbo, Paolo Corradini, et al.
Leukemia
|
August 21, 2020
Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network
Heinz Ludwig, Mario Boccadoro, Philippe Moreau, et al.
Advances in Therapy
|
December 19, 2023
Comparative Effectiveness of Teclistamab Versus Real-World Physician's Choice of Therapy in LocoMMotion and MoMMent in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma
Philippe Moreau, María-Victoria Mateos, Maria Esther Gonzalez Garcia, et al.
Cancers
|
September 9, 2023
Outcome of Second Primary Malignancies Developing in Multiple Myeloma Patients
Irit Avivi, David H Vesole, Julio Davila-Valls, et al.
Haematologica
|
January 2, 2008
Thalidomide in induction treatment increases the very good partial response rate before and after high-dose therapy in previously untreated multiple myeloma
Henk M Lokhorst, Ingo Schmidt-Wolf, Pieter Sonneveld, et al.
Leukemia & Lymphoma
|
July 3, 2018
Secondary plasma cell leukemia: a multicenter retrospective study of 101 patients
Artur Jurczyszyn, Jorge J Castillo, Irit Avivi, et al.
Leukemia
|
May 4, 2018
Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network
Heinz Ludwig, Michel Delforge, Thierry Facon, et al.
The New England Journal of Medicine
|
September 4, 2014
Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma
Lotfi Benboubker, Meletios A Dimopoulos, Angela Dispenzieri, et al.
British Journal of Haematology
|
January 10, 2018
Prognostic indicators in primary plasma cell leukaemia: a multicentre retrospective study of 117 patients
Artur Jurczyszyn, Jakub Radocha, Julio Davila, et al.
Page
of 19
Search research articles
Search
Showing results (161-170 of 188) with videos related to
Sort By:
Page
of 19
Blood
|
March 24, 2025
Daratumumab-Bortezomib-Thalidomide-Dexamethasone for Newly Diagnosed Myeloma: CASSIOPEIA Minimal Residual Disease Results
Jill Corre, Laure Vincent, Philippe Moreau, et al.
Blood
|
May 27, 2016
Safety and efficacy of pomalidomide plus low-dose dexamethasone in STRATUS (MM-010): a phase 3b study in refractory multiple myeloma
Meletios A Dimopoulos, Antonio Palumbo, Paolo Corradini, et al.
Leukemia
|
August 21, 2020
Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network
Heinz Ludwig, Mario Boccadoro, Philippe Moreau, et al.
Advances in Therapy
|
December 19, 2023
Comparative Effectiveness of Teclistamab Versus Real-World Physician's Choice of Therapy in LocoMMotion and MoMMent in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma
Philippe Moreau, María-Victoria Mateos, Maria Esther Gonzalez Garcia, et al.
Cancers
|
September 9, 2023
Outcome of Second Primary Malignancies Developing in Multiple Myeloma Patients
Irit Avivi, David H Vesole, Julio Davila-Valls, et al.
Haematologica
|
January 2, 2008
Thalidomide in induction treatment increases the very good partial response rate before and after high-dose therapy in previously untreated multiple myeloma
Henk M Lokhorst, Ingo Schmidt-Wolf, Pieter Sonneveld, et al.
Leukemia & Lymphoma
|
July 3, 2018
Secondary plasma cell leukemia: a multicenter retrospective study of 101 patients
Artur Jurczyszyn, Jorge J Castillo, Irit Avivi, et al.
Leukemia
|
May 4, 2018
Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network
Heinz Ludwig, Michel Delforge, Thierry Facon, et al.
The New England Journal of Medicine
|
September 4, 2014
Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma
Lotfi Benboubker, Meletios A Dimopoulos, Angela Dispenzieri, et al.
British Journal of Haematology
|
January 10, 2018
Prognostic indicators in primary plasma cell leukaemia: a multicentre retrospective study of 117 patients
Artur Jurczyszyn, Jakub Radocha, Julio Davila, et al.
Page
of 19